Randomized, Double-Blind Prospective Clinical Study to Examine the Mechanism of Action of IG-RD-001 (Ze-339) Compared to Desloratadine and Placebo in Patients With Seasonal Allergic Rhinitis Who Are Sensitized to Grasses.

Trial Profile

Randomized, Double-Blind Prospective Clinical Study to Examine the Mechanism of Action of IG-RD-001 (Ze-339) Compared to Desloratadine and Placebo in Patients With Seasonal Allergic Rhinitis Who Are Sensitized to Grasses.

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Jan 2012

At a glance

  • Drugs Desloratadine; IG RD 001
  • Indications Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Acronyms PETRA
  • Most Recent Events

    • 04 May 2011 New trial record
    • 11 Apr 2011 Results published in the Journal of Allergy and Clinical Immunology.
    • 11 Apr 2011 Primary endpoint "Time-to-resolution-of-nasal-symptoms" has been met, based on results published in The Journal of Allergy and Clinical Immunology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top